This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Leukamia (monocytic)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Monocytic leukaemia is a leukaemia in which the predominating leukocytes are monocytes.

It accounts for about 10% of acute myeloblastic leukaemia. Acute myeloblastic leukaemias primarily affect adults between the ages of 15 and 39 years. They constitute only 20% of childhood leukaemias. Acute myeloblastic leukaemias are extraordinarily heterogenous, reflecting the complexities of myeloid cell differentiation.

The results of organ infiltration by leukaemic cells - generalised lymphadenopathy, splenomegaly, and hepatomegaly - are not characteristic of acute myeloid leukaemia. They are more characteristic of acute lymphoid leukaemia. Bone pain and bone tenderness are common manifestations.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.